New weight drug HU6 tested in early human study
Knowledge-focused
Completed
This early-stage study looked at how safe a new drug called HU6 is and how the body processes it. Fifty-nine overweight adults took HU6 as tablets or capsules, either with or without food. The main goal was to measure drug levels in the blood, not to treat or cure a condition.
Phase: PHASE1 • Sponsor: Rivus Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 12:05 UTC